Has my stock been accused of fraud?Join over 160k users who know.

Ticker Price Change($) Change(%) Shares Volume Prev Close Open Gain($) Gain(%)
Ticker Status Jurisdiction Filing Date CP Start CP End CP Loss Deadline
Ticker Case Name Status CP Start CP End Deadline Settlement Amt
Ticker Name Date Analyst Firm Up/Down Target ($) Rating Change Rating Current

News

MSCI Reiterated FY24 Capex of $95M-$105M, Free Cash Flow of $1.225B-$1,285B

Author: Benzinga Newsdesk | July 23, 2024 06:47am

Full-Year 2024 Guidance

MSCI's guidance for the year ending December 31, 2024 ("Full-Year 2024") is based on assumptions about a number of factors, in particular related to macroeconomic factors and the capital markets. These assumptions are subject to uncertainty, and actual results for the year could differ materially from our current guidance, including as a result of the uncertainties, risks and assumptions discussed in the "Risk Factors" and "Management's Discussion and Analysis of Financial Condition and Results of Operations" sections of our Annual Report on Form 10-K, as updated in quarterly reports on Form 10-Q and current reports on Form 8-K filed or furnished with the SEC. See "Forward-Looking Statements" below.

Guidance Item

Current Guidance for Full-Year 2024

Prior Guidance for Full-Year 2024

Operating Expense

$1,305 to $1,345 million

$1,300 to $1,340 million

Adjusted EBITDA

Expense

$1,130 to $1,160 million

$1,130 to $1,160 million

Interest Expense

(including amortization

of financing fees)(1)

$185 to $189 million

$185 to $189 million

Depreciation &

Amortization Expense

$175 to $185 million

$170 to $180 million

Effective Tax Rate

18% to 21%

18% to 21%

Capital Expenditures

$95 to $105 million

$95 to $105 million

Net Cash Provided by Operating Activities

$1,330 to $1,380 million

$1,330 to $1,380 million

Free Cash Flow

$1,225 to $1,285 million

$1,225 to $1,285 million

Posted In: MSCI

CLASS ACTION DEADLINES - JOIN NOW!

NEW CASE INVESTIGATION

CORE Finalist